Skip to main content
Livermore
Livermore
ZHEN

State Street Corp

SEC CIK
0000093751
Latest filing
Sep 22, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by State Street Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by State Street Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−6,844,990−100.0%Sold outHolders
Q1 20266,844,990$275.4M<0.1%+2,231,544+48.4%AddedHolders
Q4 20254,613,446$115.9M<0.1%+575,802+14.3%AddedHolders
Q3 20254,037,644$91.4M<0.1%+474,923+13.3%AddedHolders
Q2 20253,562,721$61.7M<0.1%−378,684−9.6%ReducedHolders
Q1 20253,941,405$86.2M<0.1%−583,750−12.9%ReducedHolders
Q4 20244,525,155$144.4M<0.1%+484,294+12.0%AddedHolders
Q3 20244,040,861$116.5M<0.1%−105,833−2.6%ReducedHolders
Q2 20244,146,694$159.1M<0.1%+1,237,166+42.5%AddedHolders
Q1 20242,909,528$171.0M<0.1%−5,894−0.2%ReducedHolders
Q4 20232,915,422$174.5M<0.1%−322,692−10.0%ReducedHolders
Q3 20233,238,114$123.2M<0.1%+955,029+41.8%AddedHolders
Q2 20232,283,085$208.0M<0.1%−696,777−23.4%ReducedHolders
Q1 20232,979,862$196.6M<0.1%−492,052−14.2%ReducedHolders
Q4 20223,471,914$179.5M<0.1%+514,641+17.4%AddedHolders
Q3 20222,957,273$202.0M<0.1%−539,652−15.4%ReducedHolders
Q2 20223,496,925$158.1M<0.1%+590,469+20.3%AddedHolders
Q1 20222,906,456$147.7M<0.1%+187,088+6.9%AddedHolders
Q4 20212,719,368$128.6M<0.1%−106,827−3.8%ReducedHolders
Q3 20212,826,195$93.2M<0.1%+879,227+45.2%AddedHolders
Q2 20211,946,968$123.0M<0.1%−251,605−11.4%ReducedHolders
Q1 20212,198,573$94.3M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.